Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section
906 of the Sarbanes - Oxley Act of 2002

In connection with the quarterly report (the "Report") of China
Biopharmaceuticals Holdings, Inc. (the "Company") on Form 10-Q for the quarter
ended June 30, 2008 as filed with the Securities and Exchange Commission on the
date hereof, I, Chris Peng Mao, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act
of 2002, that to my knowledge:

i. the Report fully complies with the requirements of Section 13(a)or 15(d) of
the Securities Exchange Act of 1934; and

ii. the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

A signed original of this written statement has been provided to the Company and
will be retained by the Company and will be furnished to the Securities Exchange
Commission or its staff upon request.

                                                 /s/ Chris Peng Mao
                                                 ------------------

                                                 Chris Peng Mao
                                                 Chief Executive Officer
                                                 August 14, 2008


This Certification of Chief Executive Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 is not "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934 but is instead furnished as provided by
applicable rules of the Securities Exchange Commission.